Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 16/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 16/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.81 |
| ▸ | POLB | P06746 | 4/20 | 0.80 |
| ▸ | MAPT | P10636 | 7/20 | 0.71 |
| ▸ | MMP13 | P45452 | 2/20 | 0.71 |
| ▸ | CASP1 | P29466 | 2/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | HPGD | P15428 | 1/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.65 |
| ▸ | CASP7 | P55210 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.64 |
| ▸ | GFER | P55789 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8887899 | 1.00 | MEN1 (1.00) | MEN1KMT2ASMN1; SMN2POLBMAPT | |
| SCHEMBL7019338 | 1.00 | MEN1 (1.00) | MEN1KMT2ASMN1; SMN2POLBMAPT | |
| SCHEMBL11278635 | 0.90 | MEN1 (1.00) | MEN1KMT2ASMN1; SMN2POLBMAPT | |
| SCHEMBL11555123 | 0.90 | MEN1 (1.00) | MEN1KMT2ASMN1; SMN2POLBMAPT | |
| SCHEMBL2333246 | 0.89 | MEN1 (0.81) | MEN1KMT2ASMN1; SMN2POLBMAPT | |
| SCHEMBL15995453 | 0.89 | MEN1 (0.81) | MEN1KMT2ASMN1; SMN2POLBMAPT | |
| SCHEMBL2333243 | 0.89 | MEN1 (0.81) | MEN1KMT2ASMN1; SMN2POLBMAPT | |
| SCHEMBL9191085 | 0.89 | MEN1 (0.80) | MEN1KMT2ASMN1; SMN2POLBMAPT | |
| SCHEMBL9191082 | 0.89 | MEN1 (0.80) | MEN1KMT2ASMN1; SMN2POLBMAPT | |
| SCHEMBL194201 | 0.88 | MEN1 (0.78) | MEN1KMT2ASMN1; SMN2POLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9764046-B2 | Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method | CANON KABUSHIKI KAISHA (JP) | 2017-09-19 | — | — | US | disclosed |
| US-9764046-B2 | Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method | CANON KABUSHIKI KAISHA (JP) | 2017-09-19 | — | — | US | disclosed |
| US-20150139908-A1 | LABELING COMPOSITION FOR INTRAOCULAR TISSUE, LABELING METHOD OF INTRAOCULAR TISSUE, AND SCREENING METHOD | CANON KK (JP) | 2015-05-21 | — | — | US | disclosed |
| US-20150139908-A1 | LABELING COMPOSITION FOR INTRAOCULAR TISSUE, LABELING METHOD OF INTRAOCULAR TISSUE, AND SCREENING METHOD | CANON KK (JP) | 2015-05-21 | — | — | US | disclosed |
| US-20120035187-A1 | ANTI-NEURODEGENERATIVE DISEASE AGENT | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20120035187-A1 | ANTI-NEURODEGENERATIVE DISEASE AGENT | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20110236310-A1 | LABELING COMPOSITION FOR INTRAOCULAR TISSUE, LABELING METHOD OF INTRAOCULAR TISSUE, AND SCREENING METHOD | CANON KABUSHIKI KAISHA (JP) | 2011-09-29 | — | — | US | disclosed |
| US-20110236310-A1 | LABELING COMPOSITION FOR INTRAOCULAR TISSUE, LABELING METHOD OF INTRAOCULAR TISSUE, AND SCREENING METHOD | CANON KABUSHIKI KAISHA (JP) | 2011-09-29 | — | — | US | disclosed |
| US-7335466-B2 | Silver salt photothermographic dry imaging material, image recording method and image forming method for the same | KONICA MINOLTA HOLDINGS, INC. (JP) | 2008-02-26 | — | — | US | disclosed |
| US-7335466-B2 | Silver salt photothermographic dry imaging material, image recording method and image forming method for the same | KONICA MINOLTA HOLDINGS, INC. (JP) | 2008-02-26 | — | — | US | disclosed |
| US-7157219-B2 | Photothermographic materials containing silver halide sensitized with combination of compounds | EASTMAN KODAK COMPANY (US) | 2007-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110236310-A1 | LABELING COMPOSITION FOR INTRAOCULAR TISSUE, LABELING METHOD OF INTRAOCULAR TISSUE, AND SCREENING METHOD | ALDH1A2, PDE6C, CHAT | MEN1 2132/4885KMT2A 3911/4885SMN1; SMN2 3742/4885 |
| US-20120035187-A1 | ANTI-NEURODEGENERATIVE DISEASE AGENT | SNCA, PSEN1, CDR2 | MEN1 2218/4885KMT2A 2624/4885SMN1; SMN2 12/4885 |
| US-20150139908-A1 | LABELING COMPOSITION FOR INTRAOCULAR TISSUE, LABELING METHOD OF INTRAOCULAR TISSUE, AND SCREENING METHOD | ALDH1A2, PDE6C, CHAT | MEN1 2132/4885KMT2A 3911/4885SMN1; SMN2 3742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.